• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    More On NVO


    Novo Nordisk A/S (NVO)

    -NYSE
    43.58 0.29(0.67%) Dec 17, 4:02PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2008
    Total Revenue 13,788,000   11,588,000   8,632,294  
    Cost of Revenue2,379,000  2,199,000  1,915,656  
    Gross Profit 11,408,000   9,389,000   6,716,638  
    Operating Expenses
    Research Development1,926,000  1,682,000  1,427,125  
    Selling General and Administrative4,274,000  3,800,000  2,944,830  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 5,208,000   3,908,000   2,344,684  
    Income from Continuing Operations
    Total Other Income/Expenses Net22,000  90,000  131,134  
    Earnings Before Interest And Taxes5,230,000  3,997,000  2,452,320  
    Interest Expense316,000  168,000  46,617  
    Income Before Tax4,914,000  3,829,000  2,405,703  
    Income Tax Expense1,127,000  843,000  577,975  
    Minority Interest -   -   -  
    Net Income From Continuing Ops3,787,000  2,986,000  1,827,728  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 3,787,000   2,986,000   1,827,728  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 3,787,000   2,986,000   1,827,728  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.